Literature DB >> 24028590

Unstimulated whole salivary flow rate and anxiolytics intake are independently associated with oral Candida infection in patients with oral lichen planus.

Marija Bokor-Bratic1, Milos Cankovic, Natasa Dragnic.   

Abstract

Many factors have been proposed to influence oral infection with yeast. The aim of this study was to determine the prevalence of oral yeasts in oral lichen planus (OLP) patients and control subjects, and to perform a multiple logistic regression analysis to identify factors that influence oral Candida infection in OLP patients. In this cross-sectional study, 90 new patients with OLP and 90 sex- and age-matched control subjects with no mucosal lesions were interviewed about their health status, use of medication, and smoking and alcohol habits. Swab and unstimulated whole saliva samples were collected and salivary pH was measured. A positive Candida culture was more prevalent among OLP patients (48.9%) than among control subjects (26.7%). Candida albicans was the most frequently isolated species in both groups. By logistic regression analysis, unstimulated whole salivary flow rates of 0.11-0.24 ml min(-1) (OR = 5.90) and 0.25-0.32 ml min(-1) (OR = 3.51) and benzodiazepine anxiolytics intake (OR = 8.30) were independently associated with the presence of Candida among OLP patients. Age, denture wearing, levels of dentition, decreased salivary pH, antihypertensive drugs, and alcohol consumption were not associated with oral Candida infection in OLP patients. The results indicate that data on benzodiazepine anxiolytics intake and evaluation of unstimulated whole salivary flow rate should be considered as part of the clinical evaluation to identify OLP patients at risk for Candida infection.
© 2013 Eur J Oral Sci.

Entities:  

Keywords:  Candida infection; anxiolytics; oral lichen planus; salivary flow rate

Mesh:

Substances:

Year:  2013        PMID: 24028590     DOI: 10.1111/eos.12073

Source DB:  PubMed          Journal:  Eur J Oral Sci        ISSN: 0909-8836            Impact factor:   2.612


  7 in total

Review 1.  Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota.

Authors:  Sarah Höfs; Selene Mogavero; Bernhard Hube
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

Review 2.  Candida species colonization in oral lichen planus: A meta-analysis.

Authors:  Alberto Rodriguez-Archilla; Silvia Fernandez-Torralbo
Journal:  Int J Health Sci (Qassim)       Date:  2022 Jul-Aug

3.  Subgingival areas as potential reservoirs of different Candida spp in type 2 diabetes patients and healthy subjects.

Authors:  Sanja Matic Petrovic; Milena Radunovic; Milena Barac; Jovana Kuzmanovic Pficer; Dusan Pavlica; Valentina Arsic Arsenijevic; Ana Pucar
Journal:  PLoS One       Date:  2019-01-10       Impact factor: 3.240

4.  Salivary mycobiome dysbiosis and its potential impact on bacteriome shifts and host immunity in oral lichen planus.

Authors:  Yan Li; Kun Wang; Bo Zhang; Qichao Tu; Yufei Yao; Bomiao Cui; Biao Ren; Jinzhi He; Xin Shen; Joy D Van Nostrand; Jizhong Zhou; Wenyuan Shi; Liying Xiao; Changqing Lu; Xuedong Zhou
Journal:  Int J Oral Sci       Date:  2019-07-02       Impact factor: 6.344

Review 5.  Enzymatic Methods for Salivary Biomarkers Detection: Overview and Current Challenges.

Authors:  Alonso Ornelas-González; Margarita Ortiz-Martínez; Mirna González-González; Marco Rito-Palomares
Journal:  Molecules       Date:  2021-11-20       Impact factor: 4.411

6.  Xerostomia and Salivary Gland Hypofunction in Patients with Oral Lichen Planus Before and After Treatment with Topical Corticosteroids.

Authors:  Hala Al-Janaby; Haytham El-Sakka; Manal Masood; Walimuni Ashani W Mendis; Linda M Slack-Smith; Richard Parsons; Agnieszka M Frydrych
Journal:  Open Dent J       Date:  2017-03-31

7.  Factors influencing the presence of Candida dubliniensis and other non-albicans species in patients with oral lichen planus: a retrospective observational study.

Authors:  Florian Molkenthin; Moritz Hertel; Konrad Neumann; Andrea Maria Schmidt-Westhausen
Journal:  Clin Oral Investig       Date:  2021-06-18       Impact factor: 3.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.